Danaher Price to Free Cash Flow Ratio 2012-2025 | DHR

Historical price to free cash flow ratio values for Danaher (DHR) since 2012.
Danaher Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2026-01-22 240.08 34.68
2025-09-30 197.99 $6.92 28.60
2025-06-30 196.92 $6.72 29.29
2025-03-31 204.03 $6.74 30.28
2024-12-31 228.12 $7.20 31.68
2024-09-30 275.96 $6.84 40.33
2024-06-30 247.76 $6.87 36.09
2024-03-31 247.36 $7.45 33.20
2023-12-31 228.91 $7.80 29.36
2023-09-30 217.14 $9.22 23.55
2023-06-30 210.05 $9.80 21.44
2023-03-31 220.34 $10.00 22.03
2022-12-31 231.78 $10.05 23.06
2022-09-30 225.34 $9.58 23.53
2022-06-30 220.97 $9.66 22.89
2022-03-31 255.41 $9.79 26.09
2021-12-31 286.22 $9.68 29.57
2021-09-30 264.68 $9.79 27.03
2021-06-30 233.15 $9.47 24.61
2021-03-31 195.39 $8.79 22.23
2020-12-31 192.66 $7.54 25.55
2020-09-30 186.60 $6.15 30.33
2020-06-30 153.10 $5.15 29.71
2020-03-31 119.71 $4.77 25.07
2019-12-31 132.56 $4.59 28.89
2019-09-30 124.61 $4.84 25.77
2019-06-30 123.16 $4.82 25.57
2019-03-31 113.63 $4.66 24.39
2018-12-31 88.64 $4.85 18.28
2018-09-30 93.25 $4.30 21.67
2018-06-30 84.56 $4.55 18.59
2018-03-31 83.76 $4.57 18.34
2017-12-31 79.28 $4.16 19.04
2017-09-30 73.16 $3.86 18.96
2017-06-30 71.85 $3.48 20.63
2017-03-31 72.70 $3.84 18.93
2016-12-31 66.06 $4.20 15.71
2016-09-30 66.42 $5.06 13.13
2016-06-30 41.64 $5.39 7.73
2016-03-31 39.05 $5.09 7.66
2015-12-31 38.07 $4.73 8.05
2015-09-30 34.88 $4.82 7.24
2015-06-30 34.89 $4.77 7.31
2015-03-31 34.56 $4.62 7.48
2014-12-31 34.83 $4.59 7.59
2014-09-30 30.84 $4.24 7.27
2014-06-30 31.92 $4.17 7.65
2014-03-31 30.37 $4.07 7.47
2013-12-31 31.22 $4.27 7.31
2013-09-30 28.02 $3.92 7.15
2013-06-30 25.58 $3.96 6.46
2013-03-31 25.10 $4.14 6.06
2012-12-31 22.57 $4.15 5.44
2012-09-30 22.26 $4.22 5.27
2012-06-30 21.01 $3.83 5.49
2012-03-31 22.58 $3.44 6.57
2011-12-31 18.96 $3.27 5.80
2011-09-30 16.89 $3.01 5.61
2011-06-30 21.33 $2.97 7.17
2011-03-31 20.89 $2.82 7.41
2010-12-31 18.97 $2.77 6.84
2010-09-30 16.33 $2.66 6.14
2010-06-30 14.92 $2.59 5.77
2010-03-31 16.05 $2.53 6.34
2009-12-31 15.10 $2.43 6.22
2009-09-30 13.51 $2.43 5.56
2009-06-30 12.38 $2.32 5.33
2009-03-31 10.87 $2.46 4.41
2008-12-31 11.34 $2.48 4.57
2008-09-30 13.90 $2.60 5.35
2008-06-30 15.47 $2.54 6.08
2008-03-31 15.21 $2.27 6.71
2007-12-31 17.55 $2.28 7.71
2007-09-30 16.54 $2.17 7.64
2007-06-30 15.09 $2.23 6.76
2007-03-31 14.27 $2.15 6.64
2006-12-31 14.47 $2.18 6.62
Sector Industry Market Cap Revenue
Medical Medical Services $170.972B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
HCA Healthcare (HCA) United States $106.211B 17.58
CVS Health (CVS) United States $103.446B 11.90
Elevance Health (ELV) United States $82.202B 12.06
Cencora (COR) United States $68.237B 22.00
Natera (NTRA) United States $33.582B 0.00
DiDi Global (DIDIY) China $23.203B 21.43
Labcorp Holdings (LH) United States $22.312B 17.01
Medpace Holdings (MEDP) United States $17.481B 43.40
EUROFINS SCIENT (ERFSF) Luxembourg $15.574B 0.00
Viatris (VTRS) United States $15.031B 5.60
ICON (ICLR) Ireland $14.930B 14.81
BioMerieux (BMXMF) France $14.360B 0.00
Solventum (SOLV) United States $13.940B 13.53
Revvity (RVTY) United States $13.212B 24.33
CochLear (CHEOY) Australia $12.002B 0.00
Charles River Laboratories (CRL) United States $11.161B 21.50
Avantor (AVTR) United States $8.325B 12.72
Sonic Healthcare (SKHHY) Australia $7.861B 0.00
HealthEquity (HQY) United States $7.227B 27.03
Caris Life Sciences,�Inc (CAI) United States $7.189B 0.00
BrightSpring Health Services (BTSG) United States $7.075B 42.18
Bausch + Lomb (BLCO) Canada $6.114B 40.14
PACS (PACS) United States $5.649B 34.35
Sotera Health (SHC) United States $5.392B 26.00
Alignment Healthcare (ALHC) United States $4.662B 0.00
Amplifon S.p.A (AMFPF) Italy $3.719B 21.70
GeneDx Holdings (WGS) United States $2.892B 50.78
Concentras Parent (CON) United States $2.818B 17.59
Organon (OGN) United States $2.493B 2.63
Progyny (PGNY) United States $2.194B 43.14
Surgery Partners (SGRY) United States $2.001B 25.78
Establishment Labs Holdings (ESTA) United States $1.967B 0.00
Pediatrix Medical (MD) United States $1.895B 11.32
Ardent Health (ARDT) United States $1.223B 3.99
Teladoc Health (TDOC) United States $1.093B 0.00
CareDx (CDNA) United States $1.071B 17.50
Nutex Health (NUTX) United States $1.039B 7.95
Omada Health (OMDA) United States $0.905B 0.00
GoodRx Holdings (GDRX) United States $0.876B 14.33
InnovAge Holding (INNV) United States $0.807B 0.00
Embecta (EMBC) United States $0.730B 4.15
COMPASS Pathways (CMPS) United Kingdom $0.672B 0.00
Sonida Senior Living (SNDA) United States $0.600B 0.00
CryoPort (CYRX) United States $0.550B 0.00
Enhabit (EHAB) United States $0.544B 24.41
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
Strata Critical Medical (SRTA) United States $0.488B 0.00
SBC Medicals (SBC) United States $0.451B 8.30
Agilon Health (AGL) United States $0.395B 0.00
Auna S.A (AUNA) Luxembourg $0.365B 5.87
Oncology Institute (TOI) United States $0.332B 0.00
So-Young (SY) China $0.310B 0.00
QDM (QDMI) Hong Kong, SAR China $0.302B 63.60
Shoulder Innovations (SI) United States $0.296B 0.00
Beauty Health (SKIN) United States $0.196B 0.00
KindlyMD (NAKA) United States $0.181B 0.00
LifeMD (LFMD) United States $0.170B 0.00
Sera Prognostics (SERA) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.131B 0.00
Biodesix (BDSX) United States $0.087B 0.00
DocGo (DCGO) United States $0.083B 0.00
Park Dental Partners (PARK) United States $0.076B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.046B 0.00
IceCure Medical (ICCM) Israel $0.044B 0.00
Pomdoctor - (POM) China $0.030B 0.00
Synergy CHC (SNYR) United States $0.021B 6.34
OSR Holdings (OSRH) United States $0.018B 0.00
Basel Medical Group (BMGL) Singapore $0.015B 0.00
Lifeward (LFWD) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
INVO Fertility (IVF) United States $0.005B 0.00
ITonic Holdings (ITOC) China $0.004B 0.00
Aclarion (ACON) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
XWELL (XWEL) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.000B 0.00
Cano Health (CANOQ) United States $0.000B 0.00